Role of procalcitonin as a biomarker in early identification of adverse events following esophageal atresia surgery

Conclusions: Procalcitonin is a good indicator to identify the adverse events in neonates after surgery for esophageal atresia. The procalcitonin levels in patients who sustained a major complication depicted a reversal in trend 24–48 h of clinical manifestation. POD-1 procalcitonin correlated with survival while the baseline and POD-5 serum procalcitonin predicted the clinical course.

Source: Journal of Indian Association of Pediatric Surgeons - March 3, 2023 Category: Surgery Authors: Dhruv Mahajan Prabudh Goel Vishesh Jain Anjan Kumar Dhua Devendra Kumar Yadav Ajay Verma Ashok Sharma Surabhi Gupta Pradeep Kumar Chaturvedi Mani Kalaivani Sandeep Agarwala Minu Bajpai Source Type: research